bullish
Fancl (4921 JP): Worth A Bet Given Negative Impact Of Kobayashi Products Recall Subsiding
725 Views22 May 2024 10:57
With the nutritional supplements overhang removed, I believe the stock price is attractive at 23x 2024 PE with 15% expected earnings CAGR for the next 3 years.
What is covered in the Full Insight:
- Overview of Fancl Corp's Financial Performance
- Download On Share Price and Market Performance
- Business Segments and Sales Breakdown
- International Growth Prospects
- Margin Improvement and Projections
Boomeranged on Fri, 14 Jun 2024 08:37
Good timing - Kirin Holdings will launch a tender offer for Fancl, turning the Japanese maker of skin care products and dietary supplements into a wholly owned subsidiary. Kirin currently holds a 33% stake in Fancl shares. The offer price is expected to be at about a 30% premium to the shares' price.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
x